According to a new report, published by KBV research, The Global Medical Animation Market size is expected to reach $1.38 billion by 2031, rising at a market growth of 19.0% CAGR during the forecast period.
The Oncology segment is leading Global Medical Animation Market by Therapeutic in 2023; thereby, achieving a market value of $340.6 million by 2031, growing at a CAGR of 17.9 % during the forecast period. This can be attributed to the complex nature of cancer treatment and the increasing demand for visual content to explain the mechanisms of cancer, tumour growth, and therapeutic interventions. Medical animations in oncology are extensively used for educational purposes, patient awareness, and drug development.
The Patient Education segment exhibits a CAGR of 18.8% during (2024 - 2031). As healthcare providers strive to improve patients’ understanding of medical conditions, treatments, and procedures, animations have become essential. Medical animations simplify complex information and help patients make informed decisions about their health. This segment is particularly important in chronic disease management, surgical procedures, and personalized medicine, where clear communication is crucial for patient compliance and outcomes.
The 3D Animation segment is generating the highest revenue in the Global Medical Animation Market by Type in 2023; thereby, achieving a market value of $390.1 million by 2031. This growth is largely driven by 3D animation’s ability to provide detailed, realistic, and interactive visualizations of complex medical processes, anatomy, and surgical procedures. The technology’s ability to create highly accurate and engaging content has made it the preferred choice for medical professionals, educational institutions, and pharmaceutical companies. Additionally, 3D animations are increasingly used in patient education, helping individuals better understand medical conditions and treatments.
The Life Science Companies segment registers a CAGR of 18.7% during (2024 - 2031). Life science companies, including pharmaceutical firms, biotech companies, and research institutions, utilize medical animations to demonstrate drug mechanisms, clinical trial results, and complex biological processes. These animations are key marketing and investor presentation tools, helping communicate the efficacy and benefits of new therapies and research outcomes. The need for high-quality, visually appealing content to support drug development and commercialization has driven significant growth in this segment.
Full Report: https://www.kbvresearch.com/medical-animation-market/
The North America region dominated the Global Medical Animation Market by Region in 2023; thereby, achieving a market value of $592.1 million by 2031. The Europe region is expected to witness a CAGR of 18.5% during (2024 - 2031). Additionally, The Asia Pacific region would register a CAGR of 20% during (2024 - 2031).
By Therapeutic
By Application
By Type
By End-Use